Celldex Therapeutics
Christopher Fitzpatrick's work experience includes a role as a Research Associate at Sanofi since July 2019. Prior to that, they worked as a Quality Control Analyst II at Celldex Therapeutics since June 2012.
Christopher Fitzpatrick attended Boston University Metropolitan College from 2016 to 2019, where they obtained a Bachelor of Science degree in Biomedical Sciences, with a focus on General Biomedical Sciences.
This person is not in any offices
Celldex Therapeutics
3 followers
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as ...